Evidence map›Paper›PMID 34277470›Full record

ReviewFrontiers in cellular and infection microbiology2021

Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of

Shreya Singh, Shivaprakash M Rudramurthy, Arvind A Padhye, Basavaraj M Hemashetter, Ranganathan Iyer, Vinaykumar Hallur, Anuradha Sharma, Sourav Agnihotri, Sunita Gupta, Anup Ghosh and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Is the Exophiala complex a silent threat in Brazil? A systematic review.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Clinical and Molecular Advances on the Black YeastInternational journal of molecular sciences · 2025
    Review
  3. Article
  4. Two NovelMycobiology · 2025
    Article
  5. Article
  6. Article
  7. Name Changes for Fungi of Medical Importance, 2020 to 2021.Journal of clinical microbiology · 2023
    Review
  8. Species Diversity, Distribution, and Phylogeny ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Shreya SinghDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Shivaprakash M RudramurthyDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Arvind A PadhyeRetired, Atlanta, GA, United States.
Basavaraj M HemashetterDepartment of Microbiology, Hitech Laboratories, Belagavi, India.
Ranganathan IyerDepartment of Microbiology and Infectious Diseases, Global Hospitals, Hyderabad, India.
Vinaykumar HallurDepartment of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, India.
Anuradha SharmaDepartment of Microbiology, All India Institute of Medical Sciences, Jodhpur, India.
Sourav AgnihotriDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sunita GuptaDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Anup GhoshDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Harsimran KaurDepartment of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Post Graduate Institute of Medical Education and Research · INAID Atlanta · USAll India Institute of Medical Sciences Bhubaneswar · INAll India Institute of Medical Sciences Jodhpur · INGlobal Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Twenty-four isolates of Results: Conclusion: This, to the best of our knowledge is the first study from India elucidating the molecular and clinical characteristics of

Indexed as

ExophialaAmphotericin BAntifungal AgentsHumansIndiaMicrobial Sensitivity TestsAmphotericin BAntifungal Agentsantifungal susceptibilityExophialaIndiamolecularnovel species

Identifiers

PMID34277470
PMCPMC8284318
OpenAlexW3186324054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.